Abderrahmane Laadem
Head of Late-Stage Oncology Clinical Development @ Daiichi Sankyo
- Role
- Head of Late-stage Oncology Clinical Development at Daiichi Sankyo US
- Location
- Princeton, NJ, US
- LinkedIn followers
- 500 followers
About Abderrahmane Laadem
As the Global Head of Oncology Late-Stage Development at Daiichi Sankyo, I lead a team of dedicated professionals in advancing innovative treatments for patients with cancer. With over 30 years of experience in the pharmaceutical industry, I have a proven track record of delivering successful clinical trials and regulatory submissions, as well as building strong partnerships with key stakeholders.My career journey has taken me through various roles in early clinical development, and late-stage development, where I have contributed to the development and approval of multiple oncology and hematology products. I hold a Doctor of Medicine degree and specialization in medical oncology from Université Paris 13 and I am passionate about improving patient outcomes and advancing the field of oncology.
Experience
Head of Late-stage Oncology Clinical Development
Apr 2025 — Present
Education
Université Paris 13
Doctor of Medicine - MD, Medical Oncology Residency Program
1993 — 1997
Medical school - University of Constantine
Doctor of Medicine - MD
1985 — 1992
Find verified contacts for anyone on LinkedIn
Unifers gives sales teams verified emails and direct dials, enriched profiles, and outreach that lands in the inbox.
Free plan included · No credit card required
This profile is compiled from publicly available professional sources. Unifers is not affiliated with or endorsed by LinkedIn. Request removal of this profile.